RecruitingNCT07376603

IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features

Intensity-Modulated Radiotherapy Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features


Sponsor

Qiaojuan Guo

Enrollment

169 participants

Start Date

Jan 12, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This observational study aims to evaluate the efficacy and safety of intensity-modulated radiotherapy (IMRT) alone in patients with stage IB nasopharyngeal carcinoma (NPC) without high-risk features. The primary objective is to determine the therapeutic effectiveness of this approach


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Inclusion Criteria1

  • \. Histopathologically confirmed, newly diagnosed nasopharyngeal carcinoma 3. Age 18-70 years 4. Stage IB disease (T1-2N1M0) per the 9th edition AJCC/UICC staging system 5. Upper-neck nodal metastasis only: inferior border of every positive node at or above the inferior border of the hyoid bone 6. ECOG performance status 0-2 7. Adequate bone-marrow function

Exclusion Criteria10

  • Age > 70 years or < 18 years
  • Matted lymph nodes: two or more contiguous nodes with loss of intervening fat planes and/or extracapsular extension forming a confluent mass
  • Largest metastatic lymph-node ≥ 3 cm in the longest dimension
  • Lower-neck nodal metastasis: inferior border of any positive node below the inferior border of the hyoid bone
  • Prior malignancy except adequately treated basal-cell or squamous-cell carcinoma of the skin or carcinoma in situ of the cervix
  • Pregnancy or lactation (serum pregnancy test required for women of child-bearing potential; effective contraception mandatory during treatment)
  • Previous radiotherapy to the head-and-neck region
  • Prior chemotherapy or surgery for the primary tumour or metastatic nodes (diagnostic procedures excluded)
  • Any severe comorbidity that would confer unacceptable risk or compromise protocol adherence, including but not limited to unstable cardiac disease, renal failure, chronic hepatitis, or uncontrolled psychiatric disorder
  • History of severe hypersensitivity reactions

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONIMRT along

All patients administered with definitive radiotherapy


Locations(1)

Fujian Cancer Hospital

Fuzhou, Fujian, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07376603


Related Trials